Cargando…
PD-L1 Is Involved in the Development of Non-Hodgkin’s Lymphoma by Mediating Circulating Lymphocyte Apoptosis
Lymphocyte apoptosis plays a crucial role in tumor-induced immunosuppression. Programmed death ligand-1 (PD-L1) blocks lymphocyte activation via its receptor, PD-1. However, PD-L1/PD-1 expression and its role in enhancing immune suppression in non-Hodgkin lymphoma (NHL) have not been identified. The...
Autor principal: | Saber, Manal Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538143/ https://www.ncbi.nlm.nih.gov/pubmed/37766150 http://dx.doi.org/10.3390/vaccines11091474 |
Ejemplares similares
-
Diagnostic Performance of PD-L1 versus PD-1 Expression in Circulating CD20 Cells in Diffuse Large B-Cell Lymphoma
por: Saber, Manal Mohamed
Publicado: (2022) -
EMAP II Expression Is Increased on Peripheral Blood Cells from Non-Hodgkin Lymphoma
por: Saber, Manal Mohamed
Publicado: (2022) -
Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma
por: Saber, Manal Mohamed
Publicado: (2023) -
Lymphocyte markers in non-Hodgkin's lymphomas.
por: Payne, S. V., et al.
Publicado: (1977) -
Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma
por: Garcia-Marquez, Maria A., et al.
Publicado: (2021)